{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:17:33Z","timestamp":1793459853983,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2369-12-19","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T19:14:07Z","timestamp":1305227647000},"source":"Crossref","is-referenced-by-count":37,"title":["Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study"],"prefix":"10.1186","volume":"12","author":[{"given":"Karthik K","family":"Tennankore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D","family":"Soroka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce A","family":"Kiberd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"208_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-87-6-710","volume":"87","author":"JW Eschbach","year":"1977","unstructured":"Eschbach JW, Cook JD, Scribner BH, Finch CA: Iron balance in hemodialysis patients. Ann Intern Med. 1977, 87: 710-713.","journal-title":"Ann Intern Med"},{"key":"208_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0272-6386(88)80150-1","volume":"11","author":"JW Eschback","year":"1988","unstructured":"Eschback JW, Adamson JW: Recombinant human erythropoietin: Implications for nephrology. Am J Kidney Dis. 1988, 11: 203-209.","journal-title":"Am J Kidney Dis"},{"key":"208_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bmj.2.5546.213","volume":"2","author":"AB Shaw","year":"1967","unstructured":"Shaw AB: Hemolysis in chronic renal failure. BMJ. 1967, 2: 213-215. 10.1136\/bmj.2.5546.213.","journal-title":"BMJ"},{"key":"208_CR4","first-page":"226","volume":"276","author":"CL Hampers","year":"1980","unstructured":"Hampers CL, Streiff R, Nathan DG, Snyder D, Merrill JP: Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med. 1980, 276: 226-233.","journal-title":"N Engl J Med"},{"key":"208_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM198701083160203","volume":"316","author":"JW Eschbach","year":"1987","unstructured":"Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987, 316: 73-78. 10.1056\/NEJM198701083160203.","journal-title":"N Engl J Med"},{"key":"208_CR6","first-page":"375","volume":"20","author":"IC Macdougall","year":"2000","unstructured":"Macdougall IC: Novel erythropoiesis stimulating protein. Semin nephrol. 2000, 20: 375-381.","journal-title":"Semin nephrol"},{"key":"208_CR7","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1681\/ASN.V8121921","volume":"8","author":"F Madore","year":"1997","unstructured":"Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, Owen WF: Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol. 1997, 8: 1921-1929.","journal-title":"J Am Soc Nephrol"},{"key":"208_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","volume":"28","author":"RN Foley","year":"1996","unstructured":"Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis. 1996, 28: 53-61. 10.1016\/S0272-6386(96)90130-4.","journal-title":"Am J Kidney Dis"},{"key":"208_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1681\/ASN.2005090997","volume":"17","author":"DL Regidor","year":"2006","unstructured":"Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K: Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol. 2006, 17: 1181-1191. 10.1681\/ASN.2005090997.","journal-title":"J Am Soc Nephrol"},{"key":"208_CR10","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1093\/ndt\/gfq330","volume":"25","author":"JH Lau","year":"2010","unstructured":"Lau JH, Gangji AS, Rabbat CG, Brimble KS: Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial. Nephrol Dial Transplant. 2010, 25: 4002-4009. 10.1093\/ndt\/gfq330.","journal-title":"Nephrol Dial Transplant"},{"key":"208_CR11","doi-asserted-by":"publisher","first-page":"166.e1","DOI":"10.1053\/j.ajkd.2005.09.013","volume":"47","author":"GA Kaysen","year":"2006","unstructured":"Kaysen GA, Muller HG, Ding J, Chertow GM: Challenging the validity of the EPO index. Am J Kidney Dis. 2006, 47: 166.e1-166.e13. 10.1053\/j.ajkd.2005.09.013.","journal-title":"Am J Kidney Dis"},{"key":"208_CR12","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.2215\/CJN.02380607","volume":"2","author":"S Fishbane","year":"2007","unstructured":"Fishbane S, Besarab A: Mechanism of increased mortality risk with erythropoietin treatment to higher haematocrit targets. Clin J Am Soc Nephrol. 2007, 2: 1274-1282. 10.2215\/CJN.02380607.","journal-title":"Clin J Am Soc Nephrol"},{"key":"208_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF01757345","volume":"69","author":"P Zachee","year":"1994","unstructured":"Zachee P, Vermylen J, Boogaerts MA: Hematologic aspects of end-stage renal failure. Ann Hematol. 1994, 69: 33-40. 10.1007\/BF01757345.","journal-title":"Ann Hematol"},{"key":"208_CR14","first-page":"368","volume":"21","author":"R Afshar","year":"2010","unstructured":"Afshar R, Sanavi S, Salimi J, Ahmadzadeh M: Hematological profile of chronic kidney disease (CKD) patients in Iran, in pre-dialysis stages and after initiation of hemodialysis. Saudi J Kidney Dis Transpl. 2010, 21: 368-371.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"208_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2310\/6650.2001.34044","volume":"49","author":"VE Pollak","year":"2001","unstructured":"Pollak VE, Lorch JA, Means RT: Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients. J Investig Med. 2001, 49: 173-183. 10.2310\/6650.2001.34044.","journal-title":"J Investig Med"},{"key":"208_CR16","first-page":"190","volume":"37","author":"K Suega","year":"2005","unstructured":"Suega K, Bakta M, Dharmayudha TG, Lukman JS, Suwitra K: Profile of anemia in chronic renal failure patients: comparison between predialyzed and dialyzed patients at the Division of Nephrology, Department of Internal Medicine, Sanglah Hospital, Denpasar, Bali, Indonesia. Acta Med Indones. 2005, 37: 190-194.","journal-title":"Acta Med Indones"},{"key":"208_CR17","first-page":"393","volume":"48","author":"R Gokal","year":"1979","unstructured":"Gokal R, Weatherall DJ, Bunch C: Iron induced increase in red cell size in haemodialysis patients. Q J Med. 1979, 48: 393-401.","journal-title":"Q J Med"},{"key":"208_CR18","first-page":"63","volume":"29","author":"SJ Fleming","year":"1988","unstructured":"Fleming SJ, Wilkinson JS, Aldridge C, Greenwood RN, Muggleston SD, Baker LR, Cattell WR: Dialysis-induced change in erythrocyte volume: effect on change in blood volume calculated from packed cell volume. Clin Nephrol. 1988, 29: 63-68.","journal-title":"Clin Nephrol"},{"key":"208_CR19","first-page":"113","volume":"28","author":"PC Bartels","year":"1990","unstructured":"Bartels PC, Helleman PW, Soons JB: Investigations on red cell size distribution histograms in subjects treated by maintenance haemodialysis. J Clin Chem Clin Biochem. 1990, 28: 113-118.","journal-title":"J Clin Chem Clin Biochem"},{"key":"208_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/bmj.314.7078.430","volume":"314","author":"V Hofbrand","year":"1997","unstructured":"Hofbrand V, Provan D: ABC of clinical haematology. Macrocytic anaemias. BMJ. 1997, 314: 430-433.","journal-title":"BMJ"},{"key":"208_CR21","first-page":"19","volume":"14","author":"EP Paganini","year":"1989","unstructured":"Paganini EP, Latham D, Abdulhadi M: Practical considerations of recombinant human erythropoietin therapy. Am J Kidney Dis. 1989, 14: 19-25.","journal-title":"Am J Kidney Dis"},{"key":"208_CR22","first-page":"216","volume-title":"Erythropoiesis","author":"G Brecher","year":"1962","unstructured":"Brecher G, Stohlman F: The macrocytic response to erythropoietin stimulation. Erythropoiesis. Edited by: Jacobson LO, Doyle M. 1962, New York and London: Grune and Stratton, 216-221. 2","edition":"2"},{"key":"208_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2369-10-6","volume":"10","author":"VE Pollak","year":"2009","unstructured":"Pollak VE, Lorch JA, Shukla R, Satwah S: The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. BMC Nephrol. 2009, 10: 6-18. 10.1186\/1471-2369-10-6.","journal-title":"BMC Nephrol"},{"key":"208_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales AL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987, 40: 373-383. 10.1016\/0021-9681(87)90171-8.","journal-title":"J Chron Dis"},{"key":"208_CR25","first-page":"253","volume":"3","author":"S Beddhu","year":"2000","unstructured":"Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med. 2000, 3: 253-260.","journal-title":"Am J Med"},{"key":"208_CR26","first-page":"217","volume":"7","author":"T Fernandez","year":"2001","unstructured":"Fernandez T, Domack LB, Montes D, Pineiro R, Landrum E, Vital E: Performance Evaluation of the Coulter LH 750 Hematology Analyzer. Lab Hematol. 2001, 7: 217-228.","journal-title":"Lab Hematol"},{"key":"208_CR27","unstructured":"Final Report: The Canadian Enhancement of ICD-10 (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision). [ http:\/\/www.cihi.ca ]"},{"key":"208_CR28","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJM199808273390903","volume":"339","author":"A Besarab","year":"1998","unstructured":"Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998, 339: 584-590. 10.1056\/NEJM199808273390903.","journal-title":"N Engl J Med"},{"key":"208_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1525-139X.2009.00620.x","volume":"22","author":"DA Goodkin","year":"2009","unstructured":"Goodkin DA: The normal hematocrit cardiac trial revisited. Semin Dial. 2009, 22: 495-502. 10.1111\/j.1525-139X.2009.00620.x.","journal-title":"Semin Dial"},{"key":"208_CR30","first-page":"908","volume":"117","author":"KL Thong","year":"1977","unstructured":"Thong KL, Hanley SA, McBride JA: Clinical significance of a high mean corpuscular volume in nonanemic patients. CMAJ. 1977, 117: 908-910.","journal-title":"CMAJ"},{"key":"208_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ageing\/25.4.310","volume":"25","author":"MY Mahmoud","year":"1996","unstructured":"Mahmoud MY, Lugon M, Anderson CC: Unexplained macrocytosis in elderly patients. Age Ageing. 1996, 25: 310-312. 10.1093\/ageing\/25.4.310.","journal-title":"Age Ageing"},{"key":"208_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000169086","volume":"17","author":"A Sikole","year":"1997","unstructured":"Sikole A, Stojanovic A, Polenakovic M, Petrusevska G, Sadikario S, Saso R, Jovanovski M: How Erythropoietin Affects Bone Marrow of Uremic Patients. Am J Nephrol. 1997, 17: 128-136. 10.1159\/000169086.","journal-title":"Am J Nephrol"},{"key":"208_CR33","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","volume":"14","author":"DA Goodkin","year":"2003","unstructured":"Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003, 14: 3270-3277. 10.1097\/01.ASN.0000100127.54107.57.","journal-title":"J Am Soc Nephrol"},{"key":"208_CR34","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.2215\/CJN.00640109","volume":"4","author":"D Miskulin","year":"2009","unstructured":"Miskulin D, Bragg-Gresham J, Gillespie BW, Tentori F, Pisoni RL, Tighiouart H, Levey AS, Port FK: Key comorbid conditions that are predictive of survival among hemodialysis patients. Clin J Am Soc Nephrol. 2009, 4: 1818-1826. 10.2215\/CJN.00640109.","journal-title":"Clin J Am Soc Nephrol"},{"key":"208_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM199309303291404","volume":"329","author":"WF Owen Jr","year":"1993","unstructured":"Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993, 329: 1001-1006. 10.1056\/NEJM199309303291404.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"208_CR36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1681\/ASN.V13suppl_1s28","volume":"13","author":"AR Qureshi","year":"2002","unstructured":"Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002, 13 (Suppl 1): 128-36.","journal-title":"J Am Soc Nephrol"},{"key":"208_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10157-010-0288-x","volume":"14","author":"Y Hasuike","year":"2010","unstructured":"Hasuike Y, Nonoguchi H, Tokuyama M, Ohue M, Nagai T, Yahiro M, Nanami M, Otaki Y, Nakanishi T: Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study. Clin Exp Nephrol. 2010, 14: 349-355. 10.1007\/s10157-010-0288-x.","journal-title":"Clin Exp Nephrol"},{"key":"208_CR38","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/ajkd.2001.22433","volume":"37","author":"K Kalantar-Zadeh","year":"2001","unstructured":"Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH: Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 2001, 37: 564-572. 10.1016\/S0272-6386(01)80014-7.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-12-19\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T04:51:40Z","timestamp":1637643100000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-12-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-12-19","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]},"article-number":"19"}}